Royalty Pharma (RPRX) Insider: 144,660 Shares Converted; 33,500 Sold at $36.23
Rhea-AI Filing Summary
Gregory Norden, a director of Royalty Pharma plc (RPRX), reported a non-cash exchange and a subsequent sale of Class A ordinary shares on Form 4. On 08/08/2025 he received 144,660 Class A shares in exchange for limited partnership interests in RPI US Partners 2019, LP under an Amended and Restated Exchange Agreement, increasing his reported direct holdings to 228,348 shares prior to any sale. On 08/11/2025 he sold 33,500 shares at a weighted average price of $36.2313 per share (reported range $36.10–$36.40), reducing his direct ownership to 194,848 shares. The Form 4 was signed by an attorney-in-fact.
Positive
- Non-cash conversion of RPI US LP interests into 144,660 Class A shares, increasing direct holdings to 228,348 shares prior to the sale
- Full pricing transparency for the sale showing a weighted average price of $36.2313 and the per-share range of $36.10–$36.40
Negative
- Sale of 33,500 shares on 08/11/2025 reduced direct ownership to 194,848 shares
- Filing signed by attorney-in-fact rather than the reporting person, which may prompt investor questions about direct signatory involvement
Insights
TL;DR: Insider converted partnership interests into 144,660 Class A shares, then sold 33,500 shares at a $36.2313 weighted average.
The filing documents a routine conversion of limited partnership interests into issuer shares under a standing exchange agreement and a subsequent open-market sale. The conversion was non-cash and increased direct holdings before the sale; the sale reduced reported direct holdings to 194,848 shares. This disclosure is factual and procedural rather than a corporate-event disclosure; its market impact depends on the holder's remaining stake and broader trading context, which are not provided in the filing.
TL;DR: Director Norden reported a structured exchange of LP interests for equity followed by a partial disposal, all disclosed on Form 4.
The exchange mechanism is described in the filing: each RPI US LP interest converts to ten Class B interests and then to one Class A ordinary share for no additional consideration. The conversion and subsequent sale were reported with transaction codes consistent with an exchange (C) and sale (S), and the sale price range and weighted average are disclosed. The filing includes attorney-in-fact signature, indicating an authorized filing process.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Ordinary Shares | 33,500 | $36.2313 | $1.21M |
| Conversion | LP interests in RPI US Partners 2019, LP | 14,466 | $0.00 | -- |
| Conversion | Class A Ordinary Shares | 144,660 | $0.00 | -- |
Footnotes (1)
- These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Amended and Restated Exchange Agreement. No additional value will be paid by the Reporting Person in connection with the exchange. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.10 to $36.40 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Represents limited partnership interests in RPI US Partners 2019, LP ("RPI US LP Interests"). Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged upon such exchange for one Class A Ordinary Share of the Issuer for no additional value.
